Effects of Anesthetic Technique on NK Cells
Launched by CEDARS-SINAI MEDICAL CENTER · Jan 27, 2016
Trial Information
Current as of August 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 - 80 years old of either gender
- • Diagnosis of abdominal tumor scheduled for exploratory laparotomy with study surgeon
- • Must be able to have an epidural
- Exclusion Criteria:
- • ASA IV and above
- • Intolerance, allergy, or contraindication to use of either fentanyl or bupivacaine.
- • Significant coronary artery disease (abnormal stress test, myocardial infarction within the last 3 months)
- • Uncontrolled hypertension (BP \> 140/90)
- • Cardiac arrhythmias particularly prolonged QT syndrome
- • Drugs known to cause prolonged qT: class IA antiarrhythmics (quinidine, procainamide, dysopyramide), class III antiarrhythmics (sotalol, dofetalide, ibutalide, amiodarone), haloperidol, thioridazine, arsenic trioxide, HIV protease inhibitors, tricyclic antidepressants
- • Individuals with significant psychological disorders including: schizophrenia, mania, bipolar disorder or psychosis
- • Pregnant or lactating women
- • Morbid obesity (BMI \> 40 kg/m2) AND/OR weight \> 150 kg
- • Chronic renal failure ( creatinine \> 2.0 mg/dL)
- • Liver failure e.g., active cirrhosis
- • Alcohol or substance abuse within in the past 3 months
- • Uncorrected hypokalemia, hypomagnesemia, hypocalcemia (can be due to diuretics, mineralocorticoid use, laxatives)
- • Neuropathic pain
- • Chronic opioid consumption (\>30mg oxycodone or greater per day)
- • Cachexia from any cause
- • Systemic use of corticosteroids for greater than 2 weeks in the 6 months prior to surgery
- • HIV or other immunosuppressive condition
- • Preoperative INR \> 1.4 or platelet count \< 100
- • Sepsis or overlying skin cellulitis at epidural catheter insertion site
- • Inability to tolerate/unwillingness to have an epidural catheter for intraoperative/postoperative pain control for any reason, including prior back surgery resulting in distorted anatomy that precludes neuraxial anesthesia.
- • Inability to tolerate an epidural solution of either fentanyl or bupivacaine or needs another form of specialized pain control.
About Cedars Sinai Medical Center
Cedars-Sinai Medical Center is a renowned nonprofit academic medical center located in Los Angeles, California, recognized for its commitment to patient care, research, and education. As a leading institution in clinical trials, Cedars-Sinai harnesses innovative approaches to advance medical knowledge and improve treatment outcomes across various specialties. With a multidisciplinary team of experts, state-of-the-art facilities, and a patient-centered approach, Cedars-Sinai actively contributes to the development of novel therapies and interventions, ensuring the highest standards of clinical research while prioritizing patient safety and ethical considerations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Roya Yumul, MD, PhD
Principal Investigator
Program Director, Department of Anesthesiology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials